Objective: We analyzed the surgical result according to a management guideline based on the BRAFV600E mutation status of thyroid nodules.
目的:分析按照甲状腺结节BRAF V600E突变状态为基础的诊治指南手术的结果。
Selecting optimal second-line tyrosine kinase inhibitor therapy for chronic myeloid leukemia patients after imatinib failure: does the BCR-ABL mutation status really matter?
选择最佳的二线酪氨酸激酶抑制剂治疗伊马替尼治疗失败的慢性粒细胞白细胞患者:BCR - ABL突变状态是否真的重要?
All the patients diagnosed as suspicious for malignancy or malignant were advised to undergo an operation, and they turned out to have PTCs regardless of their BRAFV600E mutation status.
所有诊断为可疑恶性肿瘤或恶性肿瘤的患者均建议手术,结果证实为PTC,不论其BRAF V600E突变状态如何。
应用推荐